The Alere i Influenza A & B test--Courtesy of Alere Alere ($ALR) won an FDA CLIA waiver for its molecular influenza test, giving the company a boost amid ...
WALTHAM, Mass., April 2, 2015 – Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that its Alere™ i Strep A test has received marketing clearance from the U.S. Food ...
When Alere ($ALR) CEO Namal Nawana stepped in a year ago, he pledged he would get the struggling company back on track by shedding noncore businesses, cutting costs ...
Alere IncALR recently announced 510(k) approval from the U.S. Food and Drug Administration (FDA) for its Alere i RSV test, a unified solution of rapid and accurate diagnosis of RSV diseases. Notably, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results